[67Ga scintigraphy in retroperitoneal fibrosis (RPF): indications, application and clinical relevance--report of five patients].
OBJECTIVE
The aim of the study was to evaluate the indication for 67Ga-citrate imaging and its clinical impact on patients with retroperitoneal fibrosis (RPF).


METHODS
The scanning with ventral and dorsal projections was done 48 an 72 h after i.v.-injection of 370 Mbq 67Ga-citrate.


RESULTS
In the 5 patients with idiopathic RPF included in the study, there was a remarkably high correlation between the clinical symptoms, the surgical and histologic findings, the activity of the disease and the results of 67Ga-scintigraphy.


CONCLUSIONS
While CT and--maybe even better--MRI might perfectly show the extension, shape and contour of the fibrotic tissue, Gallium-67 scan appears to be superior in assessing the intensity and activity of the disease process.
Hillebrand
M
M
Urologischen Abteilung, Auguste-Viktoria-Krankenhauses Berlin-Schöneberg, Deutschland.
Gerstenberg
E
E
Kuntz
R M
RM
L'age
M
M
Grosse
G
G
D002951:Citrates; D019343:Citric Acid; D005260:Female; D005710:Gallium Radioisotopes; D006801:Humans; D008297:Male; D008875:Middle Aged; D012185:Retroperitoneal Fibrosis / Q000000981:diagnostic imaging* / Q000503:physiopathology / Q000628:therapy; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D002951:Citrates; D005710:Gallium Radioisotopes; D019343:Citric Acid
67Ga-Szintigraphie bei retroperitonealer Fibrose (RPF): Indikation, Durchführung und klinische Bedeutung.